<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Three patients receiving <z:chebi fb="0" ids="33972">gold salt</z:chebi> treatment for <z:hpo ids='HP_0001370'>rheumatoid arthritis</z:hpo> developed severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> three patients experienced remission of their disease at the time of the occurrence of marrow <z:mpath ids='MPATH_58'>aplasia</z:mpath> </plain></SENT>
<SENT sid="2" pm="."><plain>Reviewing data on these patients and recent literature indicate that fatal marrow <z:mpath ids='MPATH_58'>aplasia</z:mpath> seems to occur more frequently in sero-negative women who respond well to therapy with <z:chebi fb="0" ids="33972">gold salts</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>Frequent blood monitoring in search for any pronounced or sustained drop in red, white or platelet count, even within <z:mpath ids='MPATH_458'>normal</z:mpath> range could serve as a warning sign for myelotoxicity </plain></SENT>
<SENT sid="4" pm="."><plain>Despite intensive supportive measures and specific therapeutic attempts, <z:hpo ids='HP_0000001'>all</z:hpo> three patients eventually died of septic shock </plain></SENT>
</text></document>